Isis Pharma (ISIS) Tops Q3 EPS by 1c

Isis Pharma (NASDAQ: ISIS) reported Q3 EPS of ($0.30), $0.01 better than the analyst estimate of ($0.31). Revenue for the quarter came in at $49.1 million versus the consensus estimate of $52.93 million.

For earnings history and earnings-related data on Isis Pharma (ISIS) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Newton Golf Company (NWTG) Reports Q2 Loss of $0.49
• Star Equity Holdings (STRR) Misses Q2 EPS by 8c